500 related articles for article (PubMed ID: 1376655)
61. Prognostic impact of histological blood vessel invasion in patients with ampullary adenocarcinoma.
Kawaguchi T; Ochiai T; Ikoma H; Inoue K; Morimura R; Murayama Y; Komatsu S; Shiozaki A; Kuriu Y; Nakanishi M; Ichikawa D; Okamoto K; Fujiwara H; Kokuba Y; Sonoyama T; Otsuji E
Hepatogastroenterology; 2010; 57(104):1347-50. PubMed ID: 21443083
[TBL] [Abstract][Full Text] [Related]
62. Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: randomized controlled trial evaluating survival, morbidity, and mortality.
Yeo CJ; Cameron JL; Lillemoe KD; Sohn TA; Campbell KA; Sauter PK; Coleman J; Abrams RA; Hruban RH
Ann Surg; 2002 Sep; 236(3):355-66; discussion 366-8. PubMed ID: 12192322
[TBL] [Abstract][Full Text] [Related]
63. Impact of staging on treatment of pancreatic and ampullary cancer.
Karl RC; Carey LC
Endoscopy; 1993 Jan; 25(1):69-74. PubMed ID: 8384102
[No Abstract] [Full Text] [Related]
64. [Is resection of left-sided ductal pancreatic carcinoma of value?]].
Gebhardt C; Meyer W; Jurowich C
Zentralbl Chir; 2000; 125(12):966-9. PubMed ID: 11190614
[TBL] [Abstract][Full Text] [Related]
65. [The surgical treatment of malignant tumors of the head of the pancreas and of the periampullary area].
Veronskiĭ GI; Shtofin SG; Ivanov GV; Popov AI
Vestn Khir Im I I Grek; 1992 Jun; 148(6):288-93. PubMed ID: 1363852
[TBL] [Abstract][Full Text] [Related]
66. [Performance of reconstruction stage of the pancreatic-duodenal resection for the cancer of the pancreatic head and periampullary zone].
Bezrodnyĭ BH; Korotkyĭ VM; Khomenko DI
Klin Khir; 2009; (7-8):11. PubMed ID: 20218357
[No Abstract] [Full Text] [Related]
67. Longterm survival after pancreaticoduodenectomy for periampullary adenocarcinomas.
Chen SC; Shyr YM; Wang SE
HPB (Oxford); 2013 Dec; 15(12):951-7. PubMed ID: 23472708
[TBL] [Abstract][Full Text] [Related]
68. The correlation of cortactin and fascin-1 expression with clinicopathological parameters in pancreatic and ampulla of Vater adenocarcinoma.
Tsai WC; Lin CK; Lee HS; Gao HW; Nieh S; Chan DC; Jin JS
APMIS; 2013 Mar; 121(3):171-81. PubMed ID: 23030700
[TBL] [Abstract][Full Text] [Related]
69. Pylorus-preserving pancreatoduodenectomy. Is it an adequate cancer operation.
Tsao JI; Rossi RL; Lowell JA
Arch Surg; 1994 Apr; 129(4):405-12. PubMed ID: 7908796
[TBL] [Abstract][Full Text] [Related]
70. Predictors of survival in periampullary cancers following pancreaticoduodenectomy.
Hatzaras I; George N; Muscarella P; Melvin WS; Ellison EC; Bloomston M
Ann Surg Oncol; 2010 Apr; 17(4):991-7. PubMed ID: 20108122
[TBL] [Abstract][Full Text] [Related]
71. Prognostic significance of intratumoural microvessel density (IMD) in resected pancreatic and ampullary cancers to standard histopathological variables and survival.
Khan AW; Dhillon AP; Hutchins R; Abraham A; Shah SR; Snooks S; Davidson BR
Eur J Surg Oncol; 2002 Sep; 28(6):637-44. PubMed ID: 12359201
[TBL] [Abstract][Full Text] [Related]
72. [Risk factors of postoperative complications of pancreatoduodenectomy].
He KJ; Jiao XY; Yang XW; Hu YZ
Ai Zheng; 2008 Jan; 27(1):75-7. PubMed ID: 18184469
[TBL] [Abstract][Full Text] [Related]
73. The effect of wait times on oncological outcomes from periampullary adenocarcinomas.
McLean SR; Karsanji D; Wilson J; Dixon E; Sutherland FR; Pasieka J; Ball C; Bathe OF
J Surg Oncol; 2013 Jun; 107(8):853-8. PubMed ID: 23625192
[TBL] [Abstract][Full Text] [Related]
74. Periampullary cancer treatment in U.S. Department of Veterans Affairs hospitals: 1987-1991.
Wade TP; Coplin MA; Virgo KS; Johnson FE
Surgery; 1994 Oct; 116(4):819-25; discussion 825-6. PubMed ID: 7940184
[TBL] [Abstract][Full Text] [Related]
75. 10 years' experience treating pancreatic and periampullary cancer.
Hines LH; Burns RP
Am Surg; 1976 Jun; 42(6):441-7. PubMed ID: 59561
[TBL] [Abstract][Full Text] [Related]
76. [10 years experience in the surgical treatment of carcinoma of the pancreas and the peri-ampullary region].
Keeman JN; Schlattman TJ
Ned Tijdschr Geneeskd; 1979 Sep; 123(39):1068-74. PubMed ID: 91113
[No Abstract] [Full Text] [Related]
77. Periampullary adenocarcinoma: analysis of 5-year survivors.
Yeo CJ; Sohn TA; Cameron JL; Hruban RH; Lillemoe KD; Pitt HA
Ann Surg; 1998 Jun; 227(6):821-31. PubMed ID: 9637545
[TBL] [Abstract][Full Text] [Related]
78. Surgical treatment of pancreatic head and periampullary tumors.
Kovács I; Tóth P; Arkosy P; Hámori J; Sápy P
Acta Chir Hung; 1997; 36(1-4):172-3. PubMed ID: 9408334
[TBL] [Abstract][Full Text] [Related]
79. Ampullary region carcinomas: definition and site specific classification with delineation of four clinicopathologically and prognostically distinct subsets in an analysis of 249 cases.
Adsay V; Ohike N; Tajiri T; Kim GE; Krasinskas A; Balci S; Bagci P; Basturk O; Bandyopadhyay S; Jang KT; Kooby DA; Maithel SK; Sarmiento J; Staley CA; Gonzalez RS; Kong SY; Goodman M
Am J Surg Pathol; 2012 Nov; 36(11):1592-608. PubMed ID: 23026934
[TBL] [Abstract][Full Text] [Related]
80. [Treatment outcomes for patients with papilla of Vater cancer].
Dahl S; Bendixen M; Fristrup CW; Mortensen MB
Ugeskr Laeger; 2010 May; 172(18):1361-5. PubMed ID: 20444405
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
